Independent Dutch Study Further Validates Merlin CP-GEP Test for Melanoma Prognosis

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for dermatology, ...

SkylineDx: Independent Dutch Study Further Validates Merlin CP-GEP Test for Melanoma Prognosis

The study assessed the overall diagnostic accuracy of the Merlin CP-GEP Test for predicting sentinel node metastases and recurrence riskThe Merlin CP-GEP Test demonstrated strong predictive ...
PharmiWeb

bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034Precision Pathology Laboratory Services meets gold standard for excellence across all ...

Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care

Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...

YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap

YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced the ...